AlphaRose Therapeutics
Pre-clinicalAlphaRose Therapeutics advances genetic treatments for rare genetic diseases, aiming to bring scalable, innovative therapies to those in need.
Founded
2019
Focus
OncologyImmunology
About
AlphaRose Therapeutics advances genetic treatments for rare genetic diseases, aiming to bring scalable, innovative therapies to those in need.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedFeb 15, 2023
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile